Pharmaceuticals discovered with AI
EFFICIENT DRUG DISCOVERY & DEVELOPMENT
twoXAR Pharmaceuticals is a drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 18 diseases. twoXAR saves years in drug development while generating a 30x hit rate at in vivo efficacy milestones over traditional methods.
twoXAR Pharmaceuticals
Drug Discovery and Development Overview
May 2020
LATEST NEWS
TXR-311 Shows Promising Preclinical Efficacy and Safety in Hepatocellular Carcinoma
Targeted Oncology
June 26, 2020
LATEST EVENTS
Digital
July 14, 2020
twoXAR Pharmaceuticals CEO Andrew Radin joins a panel to discuss AI across the drug development lifecycle
Xconomy: Xcelerating Life Sciences San Francisco
San Francisco, CA (DIGITAL EVENT)
June 25, 2020
twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward"
Digital Meeting
June 8-12, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin describes how the company approaches drug discovery.
© 2020 twoXAR, Incorporated | All Rights Reserved